Report
Dave Nicoski ...
  • Ross LaDuke
EUR 42.51 For Business Accounts Only

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Upgrading SPX/QQQ/IWM Outlook to Bullish; Buy the Dips Market; Downgrading Staples

We are upgrading our outlook to bullish on the S&P 500 (SPX), Nasdaq 100, and Russell 2000 (IWM). Market dynamics have improved considerably ever since the major bullish false breakdowns at 6480-6520 on the SPX, 24,000 on Nasdaq futures (NQ), and $245 on the IWM. Everything that we see suggests bulls remain firmly in control, so we want to be buying any pullbacks for the foreseeable future to the 20-day MA or 21-day EMAs on SPX, QQQ, and IWM.

Risk-On. In addition to breakouts to all-time highs on SPX, QQQ, and IWM, additional improvements in market dynamics that supports our bullish outlook include: (1) High yield spreads are back below 320bps. (2) The U.S. dollar (DXY) remains below $100.25-$100.80 resistance and also violated its 21-day EMA support. (3) U.S. interest rate volatility (MOVE index) fell back below the crucial 85 level. (4) Semiconductors remain leadership, with the SMH ETF holding above
Underlyings
Invesco QQQ Trust, Series 1

iShares Russell 2000 Index Fund

SPDR S&P 500 ETF TRUST ADR

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch